A recent cross-sectional study published in BMC Neurology reveals that primary care physicians in Bahrain demonstrate solid foundational knowledge of multiple sclerosis demographics and diagnostics, yet exhibit notable gaps in relapse management, the McDonald criteria, and disease-modifying therapies.
In Plain English: The Clinical Takeaway
- Spotting the Signs: Most primary care doctors know common traits like the 20-to-40 age range and female predominance, but many struggle to apply advanced diagnostic frameworks like the McDonald criteria.
- Managing Relapses: Only a minority of surveyed physicians correctly identified the required 24-hour symptom duration, the 30-day interval between distinct attacks, and standard high-dose methylprednisolone protocols.
- Targeted Education: Clinical performance improved among practitioners who regularly attend seminars or see higher volumes of affected patients, highlighting a clear path for future training initiatives.
Survey Findings Across Primary Care Centers in Bahrain
Researchers evaluated primary care physicians working across health centers in Bahrain to measure baseline competencies in managing multiple sclerosis. Out of 428 invited clinicians, 211 completed the questionnaire, yielding a response rate of 49.3 percent. The resulting data exposes stark contrasts between broad epidemiological awareness and specific clinical execution.
More than half of the respondents correctly categorized multiple sclerosis as an immune-mediated disorder affecting the central nervous system. Furthermore, 67.3 percent recognized its higher prevalence in females, and most identified young adults aged 20 to 40 as the primary demographic group. When evaluating initial diagnostic tools, 75.8 percent correctly identified magnetic resonance imaging (MRI) as the preferred frontline investigation.
Diagnostic Deficiencies and Relapse Management Gaps
Despite strong foundational awareness, deep deficiencies surfaced regarding formal diagnostic thresholds and acute attack protocols. While 52.6 percent of physicians understood that diagnosis requires demonstration of dissemination in time and space, just 7.6 percent reported familiarity with the established McDonald criteria.
Nuances of acute relapse assessment proved equally challenging. Although 76.8 percent knew a relapse involves new or worsening neurological symptoms, only 33.7 percent correctly identified that those symptoms must persist for at least 24 hours. Just 44.5 percent recognized the clinical rule requiring at least 30 days of separation between discrete relapses. For acute intervention, only 41.2 percent correctly pointed to methylprednisolone at doses of 500 to 1000 milligrams as the recommended initial treatment.
Disease-Modifying Therapies and Continuing Education Impact
Familiarity with disease-modifying therapies represented another major vulnerability in primary care readiness. More than half of all respondents reported being unfamiliar with current treatments. Among the subset claiming knowledge, interferon beta stood out as the most widely recognized medication at 64.7 percent.
Statistical analysis within the study revealed that higher knowledge scores tracked with active participation in multiple sclerosis conferences, seminars, or workshops. Increased patient exposure and self-reported knowledge sufficiency also tracked with higher performance. The researchers note that connecting general practitioners with multiple sclerosis experts through formalized teamwork may mend these shortcomings, optimize medical routes, and facilitate faster, more precise identification of the condition.
References
- Elmazny A, et al. Assessment of multiple sclerosis awareness among general practitioners operating within primary health facilities in Bahrain: an observational analysis. BMC Neurol. 2026. DOI:10.1186/s12883-026-05374-7.
